Goodwin Guy 4
Research Summary
AI-generated summary
COMPASS Pathways (CMPS) CMO Guy Receives 170,600-Share Award
What Happened
- Guy Goodwin, Chief Medical Officer of COMPASS Pathways plc (CMPS), received two derivative awards on 2026-03-26 totaling 170,600 ordinary-share equivalents. The awards were granted at $0.00 (no cash paid at grant), consistent with stock-option/nominal-cost share awards rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-03-26; Form 4 filed: 2026-03-27 (timely).
- Awards: 55,000 shares (derivative) and 115,600 shares (derivative), both reported at $0.00 per share.
- Shares owned after transaction: not disclosed in this filing.
- Footnotes from the filing:
- F1: The nominal-cost share option (55,000) vests in four equal annual installments beginning March 26, 2027.
- F3: The option (115,600) vests in 48 equal monthly installments beginning April 26, 2026.
- F2: Ordinary Shares may be represented by American Depositary Shares (ADS); each ADS currently represents one Ordinary Share.
- Transaction type code: A = Award/Grant (derivative security).
Context
- These are grants of derivative awards (options/nominal-cost shares) subject to multi-year vesting—not an immediate purchase or sale. Such awards typically tie compensation to future service and company performance; they do not represent immediate cash proceeds or stock dispositions.
- Because the filing was made promptly (filed the next day), there is no late-filing flag noted.